IDEXX Labs Eyes Animal Health Growth at Morgan Stanley Forum

IDEXX Laboratories CEO to Speak at Morgan Stanley Healthcare Conference Amid Animal Health Market Growth

WESTBROOK, Maine, United States August 31, 2026 - IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, announced that its top executives will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, reinforcing the company's strategic investor engagement as the Animal Health Market continues its robust expansion trajectory.

Mike Erickson, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief Financial Officer, will represent IDEXX at the conference, scheduled from 10:45 a.m. to 11:20 a.m. ET. A live audio webcast of the fireside chat will be accessible through the company's investor relations portal at www.idexx.com/investors, with an archived edition available thereafter.

The announcement follows IDEXX's strong second quarter 2026 performance, in which the company reported revenues of $1,217 million a 10% increase on a reported basis and 9% organic growth driven by Companion Animal Group (CAG) growth of 9%, Water revenue growth of 15%, and Livestock, Poultry & Dairy (LPD) revenue growth of 11%. The results underscore IDEXX's sustained momentum as a key innovation driver within the broader animal health sector.

According to Next Move Strategy Consulting, the global Animal Health Market is projected to reach USD 80.12 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2030. Growing demand for protein-based food, heightened awareness of zoonotic diseases, and increasing government support for veterinary healthcare infrastructure are among the primary factors propelling market expansion.

Key Highlights:

IDEXX Laboratories' CEO Mike Erickson and CFO Andrew Emerson will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, from 10:45 a.m. to 11:20 a.m. ET.
The company reported Q2 2026 revenues of $1,217 million, reflecting 10% year-over-year growth on a reported basis, with Companion Animal Group (CAG) delivering 9% organic growth.
IDEXX employs approximately 11,000 people and provides diagnostic and software solutions to customers across more than 175 countries and territories.
As a member of the S&P 500™ Index, IDEXX's continued presence at major institutional investor forums reflects the animal health sector's growing prominence in global capital markets.

Analyst Insight:

According to analysts at Next Move Strategy Consulting, IDEXX Laboratories' engagement at high-profile institutional forums such as the Morgan Stanley Global Healthcare Conference reflects growing capital market confidence in the animal health sector. NMSC analysts note that as companion animal ownership rises globally and veterinary diagnostic adoption accelerates, companies with diversified portfolios spanning diagnostics, software, and water safety testing are well-positioned to capture sustained long-term growth. The convergence of precision veterinary medicine and digital health platforms is expected to attract increased institutional capital allocation in the near to medium term.

Industry Outlook:

IDEXX Laboratories' participation in the Morgan Stanley 24th Annual Global Healthcare Conference signals the animal health sector's increasing prominence within institutional investment circles. As the global animal health market advances toward its projected USD 80.12 billion valuation by 2030, companies operating at the intersection of veterinary diagnostics, precision medicine, and data-driven software platforms are expected to attract heightened investor scrutiny. The sector's long-term trajectory will be shaped by continued innovation in companion animal care, expanding livestock health management, and the broader integration of advanced diagnostic tools across veterinary practices worldwide.

Source: Business Wire

For More Information: Download FREE Sample on Animal Health Market Report

Prepared By: Sanyukta Deb

About the Author

Sanyukta Deb is a senior content writer and content analyst with expertise in content strategy, audience engagement, and research-driven storytelling. With a strong leadership approach and strategic mindset, she drives content initiatives that strengthen brand communication and audience connection. She combines creativity with analytical insight to develop impactful, value-led content while mentoring collaborative efforts across teams to ensure consistent, meaningful engagement and long-term brand growth across digital platforms.

About the Reviewer

Debashree Dey is a senior content writer and communications specialist known for crafting audience-focused narratives and insight-driven content strategies. As a published manuscript author, she combines creative storytelling with strategic thinking to strengthen brand messaging, enhance visibility, and drive meaningful audience engagement across digital platforms. With a collaborative leadership approach, she contributes to high-impact communication initiatives that ensure consistency, clarity, and long-term brand value. Outside of work, she finds inspiration in creative projects, design exploration, and storytelling-driven ideas.